Suzhou Fushilai Pharmaceutical Co. Ltd. (301258) — Cash Flow Reinvestment Rate
Suzhou Fushilai Pharmaceutical Co. Ltd. (301258) has a Cash Flow Reinvestment Rate of 2.29x as of December 2024, reinvesting CN¥107.98 Million (capex CN¥105.31 Million plus investments CN¥-2.66 Million) from operating cash flow of CN¥47.07 Million. Explore Suzhou Fushilai Pharmaceutical Co. Ltd. capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Suzhou Fushilai Pharmaceutical Co. Ltd. Cash Flow Reinvestment Rate (2019–2024)
Historical reinvestment intensity for Suzhou Fushilai Pharmaceutical Co. Ltd. across 6 annual periods. Also explore 301258 total assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Suzhou Fushilai Pharmaceutical Co. Ltd. (2019–2024)
Year-by-year capital reinvestment analysis for Suzhou Fushilai Pharmaceutical Co. Ltd.. For live market cap and broader valuation context, see Suzhou Fushilai Pharmaceutical Co. Ltd. market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 2.29x | CN¥107.98 Million | CN¥47.07 Million | CN¥105.31 Million | ▲ +60.6% |
| 2023 | 1.43x | CN¥135.38 Million | CN¥94.77 Million | CN¥41.62 Million | ▼ -82.4% |
| 2022 | 8.10x | CN¥1.22 Billion | CN¥151.19 Million | CN¥50.11 Million | ▲ +1358.8% |
| 2021 | 0.56x | CN¥110.87 Million | CN¥199.73 Million | CN¥80.75 Million | ▼ -57.8% |
| 2020 | 1.32x | CN¥219.57 Million | CN¥166.85 Million | CN¥65.69 Million | ▲ +17.6% |
| 2019 | 1.12x | CN¥168.45 Million | CN¥150.55 Million | CN¥70.93 Million | — |